• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of autoimmune diseases by OX40-OX40L interact

Research Project

Project/Area Number 12557029
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Immunology
Research InstitutionTohoku University

Principal Investigator

SUGAMURA Kazuo  Tohoku Univ. Graduate Sch. of Med., Dept. of Microbiol. & Immunol., Professor, 大学院・医学系研究科, 教授 (20117360)

Co-Investigator(Kenkyū-buntansha) ISHII Naoto  Tohoku Univ. Graduate Sch. of Med., Dept. of Microbiol. & Immunol., Research Associate, 大学院・医学系研究科, 助手 (60291267)
ASAO Hironobu  Tohoku Univ. Graduate Sch. of Med., Dept. of Microbiol. & Immunol., Associate Professor, 大学院・医学系研究科, 助教授 (80250744)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥13,200,000 (Direct Cost: ¥13,200,000)
Fiscal Year 2001: ¥6,300,000 (Direct Cost: ¥6,300,000)
Fiscal Year 2000: ¥6,900,000 (Direct Cost: ¥6,900,000)
KeywordsOX40L / OX40L-transgenic mice / CD4^+ T cells / Interstitial pneumonia / Inflammatory bowel disease / OX40L欠損マウス / 自己免疫病
Research Abstract

OX40L expressed on APCs, and its receptor, OX40 present on activated T cells, are members of the TNFR/TNF family respectively and have been located at the sites of inflammatory conditions. We have observed in OX40L-deficient mice, an impaired APC capacity, and by targeting this interaction a reduction in the symptoms of several autoimmune disorders in mice. In addition, OX40/OX40L signals are suggested to be implicated in peripheral T cell tolerance, which is a mechanism to limit autoimmunity. We have recently established OX40L transgenic (Tg) mice by using a T cell specific promoter. In these mice, failed induction of peripheral CD4^+ T-cell tolerance was observed. In addition, the OX40L-Tg mice spontaneously developed interstitial pneumonia and inflammatory bowel disease. Such autoimmune diseases were observed in OX40L-Tg mice on the C57BL/6 background but not BALB/c or DBA/1J, suggesting mice strain dependency of the disease onset. Furthermore, these diseases were completely reconstituted in Rag 2-deficient mice by introduction of OX40L-Tg CD4+ T cells and blocking of OX40/OX40L interaction completely prevented initiation of the diseases. Our findings implicate that OX40/OX4 interactions may be a vital link in a trigger of organ-specific autoimmunity.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Tateyama, M., et al.: "Expression of OX40 in muscles of polymyositis and granulomatous myopathy"J.Neurol.Sci.. 194. 29-34 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ndhlovu, L.C., et al.: "Critical involvement of OX40 ligand signals in the T-cell priming events during experimental autoimmune encephalomyelitis"J.Immunol.. 167. 2991-2999 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Baba, E. et al.: "Functional CD4 T cells after intercellular molecular transfer of OX40 ligand"J.Immunol.. 167. 875-883 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takasawa, N., et al.: "Expression of gp34 (OX40 Ligand) and OX40 on human T cell clones"Jpn.J.Cancer Res.. 92. 377-382 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Onodera.J., et al.: "Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus"Acta.Neurol.Scand. 102. 236-243 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Murata, K., et al.: "Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand"J.Exp.Med.. 191. 365-374 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tateyama, M., Fujihara, K., Ishii, N., Sugamura. K., Onodera, Y., and Itoyama, Y.: "Expression of OX40 in muscles of polymyositis and granulomatous myopathy."J. Neurol. Sci.. 194. 29-34 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ndhlovu, L. C., Ishii, N., Murata, K., Sato, T. and Sugamura, K.: "Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis."J. Immunol.. Vol. 167. 2991-2999 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Baba, E., Takahashi, Y., J. Lichtenfeld, Tanaka, R., Yoshida, A., Sugamura, K., Yamamoto, N. and Tanaka, Y.: "Functional CD4 T cells after intercellular molecular transfer of OX40 ligand."J. Immunol.. Vol. 167. 875-883 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takasawa, N., Ishii, N., Higashimura, N., Murata, K., Tanaka, Y., Nakamura, M., Sasaki, T., and Sugamura. K.: "Expression of gp34 (OX40 Ligand) and OX40 on Human T Cell Clones."Jpn. J. Cancer Res.. 92. 377-382 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Onodera, J., Nagata, T., Fujihara, K., Ohuchi, M., Ishii. N. Sugamura K. and Itoyama, K.: "Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus."Acta Neurol Scand.. 102. 236-243 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Murata. K., Ishii. N. Takano, H., Miura, S., Ndhlovu, L.C., Nose, M., Noda, T. and Sugamura, K.: "Impairment of Antigen-presenting Cell Function in Mice Lacking Expression of OX40 Ligand."J. Exp. Med.. 191. 365-374 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tateyama, M., et al.: "Expression of OX40 in muscles of polymyositis and granulomatous myopathy"J. Neurol. Sci. 194. 29-34 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ndhlovu, L.C., et al.: "Critical involvement of OX40 ligand signals in the T-cell priming events during experimental autoimmune encephalomyelitis"J.Immunol. 167. 2991-2999 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Baba, E. et al.: "Functional CD4 T cells after intercellular molecular transfer of OX40 ligand"J. Immunol. 167. 875-883 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Takasawa, N., et al.: "Expression of gp34 (OX40 Ligand) and OX40 on human T cell clones"Jpn. J.Cancer Res.. 92. 377-382 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Onodera.J., et al.: "Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus"Acta. Neurol. Scand.. 102. 236-243 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Murata, K., et al.: "Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand"J. Exp. Med.. 191. 365-374 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamada,M. 他: "Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1"Mol.Cell.Biol. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Miura,S. 他: "Hgs/Hrs, a FYVE domain protein is involved in Smad signaling through cooperation with SARA."Mol.Cell.Biol. 20. 9346-9355 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Otsu,M. 他: "In vivo competitive studies between normal and common gamma chain-defective bone marrow cells : implications for gene therapy."Hum.Gene Ther.. 11. 2051-2056 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Endo,K. 他: "STAM2, a new member of the STAM family, binding to the Janus kinases."FEBS Lett.. 477. 55-61 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi